Increasing Diversity in Clinical Trials: What Can Doctors, Regulators, and Patients Do?July 13, 2020 |
by Medical News Today
Many diseases lack effective treatments, and many researchers worldwide are trying to address these unmet needs.
Clinical trials form the cornerstone of new drug approvals, and without the volunteers who participate in clinical trials, this process would not be possible.
Yet, clinical trials overwhelmingly fail to represent the demographic diversity of the populations that the drugs in development aim to serve.